←Back to Expert Scholars
Translational Medicine / 转化医学DNA Methylation, MDS Clinical Trials
David Steensma
MD
🏢Novartis Institutes for BioMedical Research🌐USA
Global Head of Hematology Medical
90
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
David Steensma previously led MDS research at Dana-Farber and introduced the CHIP concept with colleagues. He has run pivotal trials of hypomethylating agents and combinations. He now directs hematology clinical programs in industry while maintaining academic collaborations.
Share:
🧪Research Fields 研究领域
MDS
CHIP
hypomethylating agents
clinical trials
hematologic malignancies
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 David Steensma 的研究动态
Follow David Steensma's research updates
留下邮箱，当我们发布与 David Steensma（Novartis Institutes for BioMedical Research）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment